Résultats de la recherche - 6 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
only.ConclusionWe report waning and a significant decrease in VE i and VE h from Delta to Omicron-dominant periods. Booster vaccination and prior infection attenuated these effects. Health Topics: Effectiveness and ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
status. For each period, vaccination status, and age group, we estimated risk ratios (RR) corresponding to the ratio between the probability of being hospitalised following SARS-CoV-2 infection if belonging ...
Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.
early and late AMD was calculated using random-effects meta-analysis stratified for age, birth cohort, gender, geographic region, and time period of the study. Best-corrected visual acuity (BCVA) was ...
Evolution of the implementation of a quality management system in the Belgian laboratories for anatomic pathology
computerized systems as stated in the articles 22, 24, 26, 27, 28 and 29 of the RD, respectively, should be fulfilled within a time period of three months counting from the entry into force of the license. ...
Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme.
Luxembourg laboratories, using the results obtained in the Belgian National External Quality Assessment Scheme from 2000 to 2005. METHODS: During this period, nine samples with different specificities were ...
Suicide mortality in Belgium at the beginning of the 21st century: differences according to migrant background.
accounting for socioeconomic variables. Methods: Census-linked mortality follow-up data covering the period 2001–2011 were used to probe into suicide mortality. To compare absolute differences by migrant ...